A boy with the virus-associated hemophagocytic syndrome;Een jongen met het "virus-associated hemophagocytic syndrome" (VAHS)

Tijdschrift voor Geneeskunde

Volumn 60, Issue 21, 2004, Pages 1573-1577

  Dierick, J ^a   De Backer, S ^b   Sijs, A ^a   Vanhouteghem, H ^a   Demey, K ^a   Mareen, P ^a  

^a Klinische Biologie   (Belgium)

^b AZ Maria Middelares Sint Jozef   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; CYTOKINE; DEXAMETHASONE; ETOPOSIDE; IMMUNOGLOBULIN; METHOTREXATE; PREDNISOLONE;

ANEMIA; ARTICLE; BONE MARROW EXAMINATION; CASE REPORT; CELL PROLIFERATION; CLINICAL FEATURE; DISEASE ASSOCIATION; ERYTHROPHAGOCYTOSIS; FERRITIN BLOOD LEVEL; FEVER; HEMOPHAGOCYTIC SYNDROME; HEPATOSPLENOMEGALY; HISTIOCYTE; HUMAN; HYPOFIBRINOGENEMIA; LABORATORY TEST; LIVER FUNCTION TEST; LYMPHADENOPATHY; MALE; PROGNOSIS; SCHOOL CHILD; SYNDROME DELINEATION; THROMBOCYTOPENIA; VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME; VIRUS INFECTION;

EID: 8444238881     PISSN: 0371683X     EISSN: None     Source Type: Journal    
DOI: 10.2143/TVG.60.21.1002021     Document Type: Article

References (13)

1. FAURSCHOU M, NIELSEN OJ, HANSEN PB, JUHL BR, HASSELBALCH H. Fatal virus-associated hemophagocytic syndrome associated with coexistent chronic active hepatitis B and acute hepatitis C virus infection. Am J Hematol 1999; 6: 135-138.
2. HESS EH. Hemophagocytic syndromes. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN, eds. Wintrobe's clinical hematology. Philadelphia: Lea & Febiger, 1993: 2189-2191.
3. VAN DIJKEN PJ, KUIS W, BAKKER RJ, STOOP JW. Een patient met het "virus-associated hemophagocytic syndrome". Ned Tijdschr Geneeskd 1986; 130: 1450-1452.
4. ROTH B, GRANDE PO, NILSSON-EHLE P, ELIASSON I. Possible role of short-term parenteral nutrition with fat emulsions for development of haemophagocytosis with multiple organ failure in a patient with traumatic brain injury. Intensive Care Med 1993; 19: 111-114.
5. LINDHOLM M. Role of short-term parenteral nutrition with fat emulsion in haemophagocytosis syndrome (comment). Intensive Care Med 1994; 20: 398-399.
6. ESUMI N, IKUSHIMA S, TODO S, IMASHUKU S. Hyperferritinemia in malignant histiocytosis, virus-associated hemophagocytic syndrome and familial erythrophagocytic lymphohistiocytosis. A survey of pediatric cases. Acta Paediatr Scand 1989; 78: 268-270.
7. OKANO O, GROSS TG. Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. Am J Hematol 1996; 53: 111-115.
8. PALUMBO GA, ROMEO MA, DI RAIMONDO F, GALVAGNO F. MILONE G. Altered immunoregulation by selective expression of Th1-type cytokine mRNAs in hemophagocytic syndrome patients. Hematologica 1998; Suppl 9: 21.
9. FAURSCHOU M, NIELSEN OJ, HANSEN PB, HASSELBALCH H. Virus-associated hemophagocytic syndrome. Diagnosis and treatment. Ugeskr Laeger 1998; 160: 6189-200.
10. QARI M, ROBERTS GT. Improving the diagnostic precision of bone marrow examination for hemophagocytic syndromes. Lab Hematol 1999; 5: 37-42.
11. GILL DS, SPENCER A, COBCROFT RG. High-dose gamma-globulin therapy in the reactive haemophagocytic syndrome. Br J Haematol 1994; 88: 204-206.
12. RENTER JL, SAMUELSSON-HORNE A, ARICO M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100: 2367-2373 (http://www.bloodjournal.org/ cgi/content/full/100/7/2367).
13. IMASHUKLT S, HIBI S, OHARA T, et al. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society. Blood 1999; 93: 1869-1874 (http://www.bloodjournal.org/cgi/ content/full/93/6/1869).